PT Kimia Farma Sungwun Pharmacopia, abbreviated as KFSP, is a subsidiary of PT Kimia Farma Tbk. which is engaged in manufacturing raw materials, both active pharmaceutical raw materials and other chemical raw materials. KFSP is a Joint Venture between PT Kimia Farma Tbk. with Sungwun Pharmacopia Co Ltd. with the composition of shareholders of PT Kimia Farma Tbk. by 80.67% and Sungwun Pharmacopia Co Ltd. by 19.33%.

The company is engaged in the production, processing, marketing, and distribution of chemicals, pharmaceuticals, biologics, and other raw materials in Indonesia.

Currently, KFSP has produced 17 (seventeen) items of medicinal raw materials: Simvastatin, Atorvastatin Calcium Trihydrate, Rosuvastatin, Clopidogrel Bisulfate Form II, Lamivudine, Zidovudine, Tenofovir Disoproxil Fumarate, Efavirenz, Entecavir, Remdesivir, Gefitinib, Amlodipine, Camdesartan, Bisoprolol, Azithromycin, Attapulgite and Povidone Iodine. Also, several HFC (High Function Chemical) products have been produced, namely: Palmitic Acid Mixtures, Lauroyl Lysine, Cholesteryl Chloride, Cholesteryl Nonanoate, Ethyl-hexanoic Acid Mixture (EG), and Lauroyl Glutamide Mixture (LG).

KFSP is a subsidiary of PT Kimia Farma Tbk. which is a Pharmaceutical State-Owned Company (BUMN) in Indonesia.

For more information and ordering our products, kindly reach us through email: sales@kfsp.co.id or phone: +622189916857